Renal cell carcinoma (RCC) remains one of the most angiogenesis-dependent solid tumors, characterized by constitutive activation of hypoxia-inducible signaling and resistance to long-term anti-VEGF therapies. Emerging evidence suggests that complex dietary bioactives may exert multi-targeted anti-neoplastic effects beyond single-molecule pharmacology. Here, i propose and mechanistically explore Phaseolus vulgaris (red kidney bean) as a source of integrated anti-angiogenic bioactive complexes composed of polyphenols,saponins, and fermentable fiber-derived metabolites. I demonstrate that these legume-derived compounds act synergistically to suppress RCC proliferation, disrupt tumor-driven angiogenesis, and reprogram metabolic and inflammatory signaling pathways. This work introduces a novel framework positioning legume bioactives as systems-level modulators of renal oncogenesis, opening avenues for complementary nephro-oncological strategies.